Data were collected from 54 patients aged between 6 and 59 years that had a confirmed diagnosis of migraine according to the 3rd Edition of the International Headache Classification of the International Headache Society of 2018, and were treated for TMJC in a dental clinic. They also presented with other otolaryngological symptoms. A retrospective quasi-experimental study without a control group was carried out due to ethical considerations related to the harmless nature of the treatment.
After treatment of TMJC, migraine symptoms disappeared in 52 patients (96.3%, P<.001), and persisted, although with clinical improvement, in 2 (3.7%). There was also an improvement in the other associated symptoms: dizziness disappeared in 23 out of 27 affected patients (85.21%, P<.001), and tinnitus disappeared in the 31 affected patients (100%, P<.001). No significant treatment-related side effects were observed.
This study shows the high rate of response and safety of the treatment of TMJC.
Copyright © 2020 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.